A M-cholinomimetic agent is:

Questions 265

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan Questions

Question 1 of 5

A M-cholinomimetic agent is:

Correct Answer: D

Rationale: In pharmacology, understanding the classification and mechanisms of action of different drugs is crucial. In this question, the correct answer is D) Bethanechol. Bethanechol is a M-cholinomimetic agent that specifically acts on muscarinic receptors in the parasympathetic nervous system. It is commonly used to stimulate bladder contractions in cases of urinary retention. Now, let's explore why the other options are incorrect: A) Carbachol: Carbachol is also a cholinomimetic agent, but it acts on both nicotinic and muscarinic receptors, not solely on M-cholinergic receptors like bethanechol. B) Intersphic: This is a non-existent drug and does not fall under the category of M-cholinomimetic agents. C) Acetylcholine: While acetylcholine is a neurotransmitter that acts on cholinergic receptors, it is not a synthetic cholinomimetic drug like bethanechol. In an educational context, understanding the specific actions and classifications of drugs like M-cholinomimetic agents is fundamental for pharmacology students and healthcare professionals. This knowledge is essential for making informed decisions regarding drug selection, dosing, and potential side effects when treating patients across the lifespan. Understanding the differences between similar drugs can prevent medication errors and ensure safe and effective patient care.

Question 2 of 5

Which of the following agents is a ganglion-blocking drug?

Correct Answer: B

Rationale: In pharmacology, understanding the mechanisms of action of different drug classes is crucial for safe and effective patient care. In this case, the correct answer is B) Hexamethonium, a ganglion-blocking drug. Ganglion blockers act on autonomic ganglia, blocking nicotinic cholinergic receptors and thereby blocking both sympathetic and parasympathetic pathways. Homatropine (A) is an anticholinergic agent used to dilate the pupil. Rapacuronium (C) is a neuromuscular blocking agent used for muscle relaxation during surgery. Edrophonium (D) is an acetylcholinesterase inhibitor used for diagnosing myasthenia gravis. Understanding the role of ganglion blockers is essential in managing conditions like autonomic dysreflexia, severe hypertension, and certain types of neuropathic pain. By knowing the specific actions of each drug class, healthcare providers can make informed decisions regarding drug selection and monitor for potential side effects or interactions.

Question 3 of 5

Atropine is frequently used prior to administration of inhalant anesthetics to reduce:

Correct Answer: B

Rationale: Atropine is frequently used prior to administration of inhalant anesthetics to reduce secretions because atropine is an anticholinergic drug that blocks the action of acetylcholine, thereby reducing the production of saliva and other secretions in the respiratory tract. This drying effect is crucial in preventing complications such as bronchospasm or airway obstruction during anesthesia. Regarding the other options: A) Muscle tone: Atropine can actually increase muscle tone due to its anticholinergic effects, leading to potential issues in certain situations, such as in patients with certain neuromuscular disorders. C) Nausea and vomiting: Atropine is not primarily used to address nausea and vomiting. Other antiemetic medications would be more appropriate for this purpose. D) All of the above: While atropine does have various effects on the body, its primary use in this context is to reduce secretions, making option B the most relevant choice. Understanding the rationale behind atropine's use in anesthesia is crucial for healthcare providers, especially those involved in administering anesthesia or caring for patients undergoing procedures that require anesthesia. By knowing the specific effects and purposes of atropine, healthcare professionals can ensure safe and effective care for patients across the lifespan.

Question 4 of 5

Antimuscarinics are used in the treatment of the following disorders EXCEPT:

Correct Answer: B

Rationale: Antimuscarinic drugs are medications that block the action of acetylcholine at muscarinic receptors in the body. In the context of pharmacology across the lifespan, understanding the appropriate use of antimuscarinics is crucial for safe and effective patient care. The correct answer is B) Glaucoma. Antimuscarinic drugs are not typically used in the treatment of glaucoma. In fact, they can increase intraocular pressure, exacerbating the condition. A) Motion sickness: Antimuscarinics like scopolamine are commonly used to prevent motion sickness by reducing the activity of the vestibular system. C) Hyperhidrosis: Antimuscarinics can be used to decrease sweating in conditions like hyperhidrosis by blocking the action of acetylcholine on sweat glands. D) Asthma: While antimuscarinics are not the first-line treatment for asthma, they can be used as an add-on therapy in some cases to help relax airway smooth muscles. Educationally, knowing the appropriate uses of antimuscarinics helps healthcare providers make informed decisions when selecting medications for different conditions, considering factors like age, comorbidities, and potential side effects. Understanding the contraindications, side effects, and therapeutic uses of antimuscarinic drugs is essential for pharmacology practice across the lifespan.

Question 5 of 5

Which of the following drugs has ‘double-acetylcholine’ structure?

Correct Answer: D

Rationale: In pharmacology across the lifespan, understanding the structures and mechanisms of action of different drugs is crucial for safe and effective practice. In this case, the correct answer is D) Succinylcholine. Succinylcholine has a unique double-acetylcholine structure, which allows it to act as a depolarizing neuromuscular blocking agent. This structure mimics acetylcholine and leads to sustained depolarization of the motor endplate, resulting in muscle paralysis. A) Rocuronium is a non-depolarizing neuromuscular blocking agent that acts by competitively blocking acetylcholine from binding to nicotinic receptors. B) Carbachol is a cholinomimetic drug that is a synthetic choline ester and does not have a double-acetylcholine structure. C) Atracurium is another non-depolarizing neuromuscular blocking agent that works by competitive inhibition of acetylcholine at the motor endplate. Educationally, knowing the specific structures of drugs helps healthcare professionals understand their mechanisms of action, side effects, and potential interactions. This knowledge is essential for making informed decisions when prescribing medications and managing patient care across the lifespan.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions